Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine

Title: Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine
Authors: Yelehe-Okouma, Melissa; Martini, Hervé; Lemarié, Jérémie; Labroca, Pierre; Petitpain, Nadine; Gibaja, Valérie; Paille, François; Gillet, Pierre
Contributors: Service de Pharmacologie Clinique et Toxicologie CHRU Nancy; Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy); Service de Réanimation Médicale CHRU Nancy; Service de Réanimation Médicale, Hôpital de Mercy CHR Metz-Thionville; Centre hospitalier régional de Metz-Thionville (CHR Metz-Thionville); Csapa - Maison des Addictions Chru Nancy Central (MdA); Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA); Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS)
Source: ISSN: 0767-3981.
Publisher Information: CCSD; Wiley
Publication Year: 2017
Collection: Université de Lorraine: HAL
Subject Terms: opioid withdrawal syndrome; nalmefene; opioid substitution therapy; [SDV]Life Sciences [q-bio]; [SDV.TOX]Life Sciences [q-bio]/Toxicology
Description: International audience ; Opioid antagonists such as naltrexone and nalmefene are used in drug therapy for alcoholism. Nalmefene, approved in Europe in February 2013 for the reduction of alcohol consumption, is used in patients with alcohol dependence. We report 11 cases of opioid withdrawal syndrome after a single dose of nalmefene in patients usually treated with methadone, buprenorphine, but also with fentanyl or loperamide. Nalmefene is both a partial agonist and an antagonist of opioid receptors. Regarding to its opioid antagonist activity, nalmefene is contraindicated in patients with an opioid treatment. Therefore, when prescribing or delivering nalmefene, healthcare professionals need to be vigilant about any type of opioid exposure, even masked or hidden, to avoid these potential life-threatening syndromes.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/28322465; PUBMED: 28322465
DOI: 10.1111/fcp.12286
Availability: https://hal.science/hal-01713582; https://doi.org/10.1111/fcp.12286
Accession Number: edsbas.40129A76
Database: BASE